These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

563 related items for PubMed ID: 18056471

  • 1. Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells.
    Moeller M, Kershaw MH, Cameron R, Westwood JA, Trapani JA, Smyth MJ, Darcy PK.
    Cancer Res; 2007 Dec 01; 67(23):11428-37. PubMed ID: 18056471
    [Abstract] [Full Text] [Related]

  • 2. IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.
    Rodolfo M, Zilocchi C, Accornero P, Cappetti B, Arioli I, Colombo MP.
    J Immunol; 1999 Aug 15; 163(4):1923-8. PubMed ID: 10438927
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
    Huang H, Li F, Gordon JR, Xiang J.
    Cancer Res; 2002 Apr 01; 62(7):2043-51. PubMed ID: 11929823
    [Abstract] [Full Text] [Related]

  • 5. Adoptive transfer of gene-engineered CD4+ helper T cells induces potent primary and secondary tumor rejection.
    Moeller M, Haynes NM, Kershaw MH, Jackson JT, Teng MW, Street SE, Cerutti L, Jane SM, Trapani JA, Smyth MJ, Darcy PK.
    Blood; 2005 Nov 01; 106(9):2995-3003. PubMed ID: 16030195
    [Abstract] [Full Text] [Related]

  • 6. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus.
    Patel DR, Li W, Park JS, Sofi MH, Gourley TS, Hangoc G, Kaplan MH, Chang CH.
    Cell Immunol; 2005 Jan 01; 233(1):30-40. PubMed ID: 15876426
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y, Hiraoka S, Tomura M, Zhou XY, Yashiro-Ohtani Y, Mori Y, Shimizu J, Ono S, Dunussi-Joannopoulos K, Wolf S, Fujiwara H.
    Int Immunol; 2005 Jan 01; 17(1):73-83. PubMed ID: 15569772
    [Abstract] [Full Text] [Related]

  • 10. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
    Ye Z, Tang C, Xu S, Zhang B, Zhang X, Moyana T, Yang J, Xiang J.
    Cell Mol Immunol; 2007 Aug 01; 4(4):277-85. PubMed ID: 17764618
    [Abstract] [Full Text] [Related]

  • 11. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
    Kang H, Choi TW, Ahn KS, Lee JY, Ham IH, Choi HY, Shim ES, Sohn NW.
    J Ethnopharmacol; 2009 May 04; 123(1):6-14. PubMed ID: 19429332
    [Abstract] [Full Text] [Related]

  • 12. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L, Castellani P, Meazza R, Tosi G, De Lerma Barbaro A, Procopio FA, Comes A, Zardi L, Ferrini S, Accolla RS.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [Abstract] [Full Text] [Related]

  • 13. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
    Hazlett LD, McClellan S, Kwon B, Barrett R.
    Invest Ophthalmol Vis Sci; 2000 Mar 01; 41(3):805-10. PubMed ID: 10711697
    [Abstract] [Full Text] [Related]

  • 14. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O, Schulze-Garg C, Warnecke G, Gugel R, Löhler J, Deppert W.
    J Virol; 2001 Nov 01; 75(22):10593-602. PubMed ID: 11602701
    [Abstract] [Full Text] [Related]

  • 15. Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis.
    Shibolet O, Kalish Y, Klein A, Alper R, Zolotarov L, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y.
    J Leukoc Biol; 2004 Jan 01; 75(1):76-86. PubMed ID: 14557387
    [Abstract] [Full Text] [Related]

  • 16. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse.
    Takeshita K, Yamasaki T, Akira S, Gantner F, Bacon KB.
    Int Immunol; 2004 May 01; 16(5):685-95. PubMed ID: 15096484
    [Abstract] [Full Text] [Related]

  • 17. Combined CD4+ Th1 effect and lymphotactin transgene expression enhance CD8+ Tc1 tumor localization and therapy.
    Huang H, Bi XG, Yuan JY, Xu SL, Guo XL, Xiang J.
    Gene Ther; 2005 Jun 01; 12(12):999-1010. PubMed ID: 15789061
    [Abstract] [Full Text] [Related]

  • 18. Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4(+) T cells.
    Deboy CA, Xin J, Byram SC, Serpe CJ, Sanders VM, Jones KJ.
    Exp Neurol; 2006 Sep 01; 201(1):212-24. PubMed ID: 16806176
    [Abstract] [Full Text] [Related]

  • 19. Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer.
    Nakamori M, Iwahashi M, Nakamura M, Ueda K, Zhang X, Yamaue H.
    Clin Cancer Res; 2003 Jun 01; 9(6):2357-65. PubMed ID: 12796406
    [Abstract] [Full Text] [Related]

  • 20. Characterization of tumor-infiltrating CD4+ T cells as Th1 cells based on lymphokine secretion and functional properties.
    Nagarkatti M, Clary SR, Nagarkatti PS.
    J Immunol; 1990 Jun 15; 144(12):4898-905. PubMed ID: 1972170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.